We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 1,573 results
  1. Imbalance of the von Willebrand Factor — ADAMTS-13 axis in patients with retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S)

    Background

    Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S) is an ultra-rare, autosomal-dominant small...

    Max Braune, Moritz Metelmann, ... Johann Otto Pelz in Neurological Research and Practice
    Article Open access 20 June 2024
  2. Incidence of thrombotic microangiopathies in Quebec: insight from a laboratory centralizing ADAMTS-13 testing

    Background

    Thrombotic microangiopathies (TMA) are serious medical conditions requiring a prompt diagnosis to adapt treatment. The determination of...

    Clémence Merlen, Emmanuelle Pépin, ... Arnaud Bonnefoy in Orphanet Journal of Rare Diseases
    Article Open access 04 August 2022
  3. Upshaw–Schulman Syndrome with a Novel Deletion in Exon 17 of ADAMTS 13 Gene

    Upshaw–Schulman syndrome is a rare congenital form of thrombotic thrombocytopenic purpura (TTP) characterized by single or recurrent episodes of...

    B. M. John, Shyam Kumar, Apoorv Saxena in Indian Journal of Pediatrics
    Article 23 January 2022
  4. Therapeutic application of recombinant human ADAMTS-13 improves shock reversal and coagulation status in a trauma hemorrhage and transfusion rat model

    Introduction

    In hemorrhaging trauma patients, the endothelium is activated, resulting in excessive endothelial synthesis of von Willebrand Factor...

    Mathijs R. Wirtz, Daan P. van den Brink, ... Nicole P. Juffermans in Intensive Care Medicine Experimental
    Article Open access 18 December 2020
  5. Von Willebrand factor:antigen and ADAMTS-13 level, but not soluble P-selectin, are risk factors for the first asymptomatic deep vein thrombosis in cancer patients undergoing chemotherapy

    Background

    There is a high incidence of deep vein thrombosis (DVT) among cancer patients undergoing chemotherapy. Chemotherapy-induced vascular...

    Budi Setiawan, Cecilia Oktaria Permatadewi, ... Catharina Suharti in Thrombosis Journal
    Article Open access 11 November 2020
  6. Decreased activity of plasma ADAMTS-13 predicts poor prognosis in acute lymphoblastic leukemia patients after hematopoietic stem cell transplant

    Decreased ADAMTS-13 is important for the diagnosis of thrombotic thrombocytopenic purpura (TTP), but recent studies have shown that reduced ADAMTS-13...

    Zhenxue Li, **aoning Chen, ... Chen Liu in Journal of Hematopathology
    Article 03 January 2020
  7. Low ADAMTS 13 plasma levels are predictors of mortality in COVID-19 patients

    Mario Bazzan, Barbara Montaruli, ... Dario Roccatello in Internal and Emergency Medicine
    Article 18 June 2020
  8. ADAMTS-13–VWF axis in sickle cell disease patients

    Sickle cell disease (SCD) comprises a group of genetic disorders characterized by the presence of the hemoglobin (Hb) S in homozygosis or in...

    Valéria Sutana Ladeira, Amanda Rodrigues Barbosa, ... Danyelle Romana Alves Rios in Annals of Hematology
    Article 06 January 2021
  9. Weibel-Palade bodies: function and role in thrombotic thrombocytopenic purpura and in diarrhea phase of STEC-hemolytic uremic syndrome

    Abstract

    Vascular endothelial cells are equipped with numerous specialized granules called Weibel-Palade bodies (WPBs). They contain a cocktail of...

    Leo Monnens in Pediatric Nephrology
    Article Open access 05 July 2024
  10. Clinical characteristics of anti-GBM disease with thrombotic microangiopathy: a case report and literature review

    The coexistence of anti-glomerular basement membrane (anti-GBM) disease with thrombotic microangiopathy (TMA) is rarely encountered, and the clinical...

    Yoshihiro Nakamura, Noritoshi Kato, ... Shoichi Maruyama in CEN Case Reports
    Article 22 May 2023
  11. Long noncoding RNA PVT1 promotes chondrocyte extracellular matrix degradation by acting as a sponge for miR-140 in IL-1β-stimulated chondrocytes

    Background

    Osteoarthritis (OA) is a common degenerative joint disease, and chondrocyte extracellular matrix (ECM) degradation is one vital...

    Nan Yao, Sha Peng, ... Dane Huang in Journal of Orthopaedic Surgery and Research
    Article Open access 10 April 2022
  12. Pregnancy-onset thrombotic thrombocytopenic purpura with nephrotic syndrome: a case report

    Pregnancy-onset thrombotic thrombocytopenic purpura (TTP) was reported by many obstetricians and hematologists, but less by nephrologists, and the...

    Ryunosuke Noda, Yuki Kakinuma, ... Yoshitaka Ishibashi in CEN Case Reports
    Article 08 October 2021
  13. New evidence on the controversy over the correlation between vertebral osteoporosis and intervertebral disc degeneration: a systematic review of relevant animal studies

    Objective

    The effect of vertebral osteoporosis on disc degeneration remains controversial. The aim of this study was to conduct a systematic review...

    Wenhao Li, Yiqun Niu, ... **ng Yu in European Spine Journal
    Article 20 April 2024
  14. Two ischemic stroke events within 48 h: a case report of an unusual presentation of thrombotic thrombocytopenic purpura

    Background

    Thrombotic thrombocytopenic purpura (TTP) considers a rare cause of ischemic stroke (IS). We reported a case of a newly diagnosed patient...

    Melika Jameie, Sanaz Heydari, ... Hamed Amirifard in BMC Neurology
    Article Open access 28 January 2023
  15. PDK4 inhibits osteoarthritis progression by activating the PPAR pathway

    Background

    Osteoarthritis (OA) is a degenerative joint disease caused by the deterioration of cartilage. However, the underlying mechanisms of OA...

    Zhengnan Li, Lifeng **e, ... Yaohong Wu in Journal of Orthopaedic Surgery and Research
    Article Open access 02 February 2024
  16. First diagnosis of thrombotic thrombocytopenic purpura after SARS-CoV-2 vaccine – case report

    Background

    We report a case of a 25-year-old male patient, who developed acquired thrombotic thrombocytopenic purpura (aTTP) after receiving a first...

    Bilgin Osmanodja, Adrian Schreiber, ... Evelyn Seelow in BMC Nephrology
    Article Open access 11 December 2021
  17. Hämoperfusion und Plasmapherese auf der Intensivstation

    In addition to kidney replacement procedures, several other extracorporeal procedures are employed in the intensive care unit. Hemoperfusion with...

    Jan T. Kielstein in Wiener klinisches Magazin
    Article 01 March 2023
  18. Hämoperfusion und Plasmapherese auf der Intensivstation

    In addition to kidney replacement procedures, several other extracorporeal procedures are employed in the intensive care unit. Hemoperfusion with...

    Jan T. Kielstein in Die Nephrologie
    Article 21 December 2022
  19. Thrombotic thrombocytopenic purpura presenting as stroke mimics with normal diffusion-weighted MRI

    Background

    Thrombotic thrombocytopenic purpura (TTP) is a rare and fatal thrombotic microangiopathy-based hematologic disease. Stroke has been...

    Ziyi Zhang, Miao He in BMC Neurology
    Article Open access 11 December 2023
  20. Thrombotic thrombocytopenic purpura developed after pegylated interferon treatment for hepatitis B infection

    Background

    Thrombotic thrombocytopenic purpura (TTP) is a rare and life-threatening thrombotic microangiopathy characterized by microangiopathic...

    Shuqin Mei, Yun Feng, ... Yixin Qian in BMC Nephrology
    Article Open access 13 December 2022
Did you find what you were looking for? Share feedback.